FOLR1 and metastatic neoplasm: In both localized and metastatic disease models, human T cells were detected in peripheral blood on day 5, with increased population detected in mice treated with FH FOLR1-CART compared with a negligible population in mice that received NT T cells (Supplementary Fig. S5).